Success Metrics

Clinical Success Rate
50.0%

Based on 1 completed trials

Completion Rate
50%(1/2)
Active Trials
1(17%)
Results Posted
100%(1 trials)
Terminated
1(17%)

Phase Distribution

Ph phase_2
2
33%
Ph phase_3
3
50%
Ph not_applicable
1
17%

Phase Distribution

0

Early Stage

2

Mid Stage

3

Late Stage

Phase Distribution6 total trials
Phase 2Efficacy & side effects
2(33.3%)
Phase 3Large-scale testing
3(50.0%)
N/ANon-phased studies
1(16.7%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

25.0%

1 of 4 finished

Non-Completion Rate

75.0%

3 ended early

Currently Active

1

trials recruiting

Total Trials

6

all time

Status Distribution
Active(1)
Completed(1)
Terminated(3)
Other(1)

Detailed Status

Withdrawn2
Completed1
Recruiting1
unknown1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
1
Success Rate
50.0%
Most Advanced
Phase 3

Trials by Phase

Phase 22 (33.3%)
Phase 33 (50.0%)
N/A1 (16.7%)

Trials by Status

completed117%
withdrawn233%
recruiting117%
unknown117%
terminated117%

Recent Activity

1 active trials
Showing 5 of 6
recruitingphase_2

Alanyl-glutamine Supplementation for C. Difficile Treatment (ACT)

NCT04305769
unknownnot_applicable

Effect of IV Alanyl Glutamine on Healing of Pressure Ulcers in Critically Ill Patients

NCT05586646
terminatedphase_2

Alanyl-glutamine Supplementation of Standard Treatment for C. Difficile Infection

NCT02053350
completedphase_3

Intervention and Mechanisms of Alanyl-Glutamine for Inflammation, Nutrition, and Enteropathy

NCT01832636
withdrawnphase_3

HIAS II - Study of Nutritional Supplementation in Hospitalized Children With Persistent Diarrhea or Malnutrition

NCT00133562
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT04305769Phase 2

Alanyl-glutamine Supplementation for C. Difficile Treatment (ACT)

Recruiting
NCT05586646Not Applicable

Effect of IV Alanyl Glutamine on Healing of Pressure Ulcers in Critically Ill Patients

Unknown
NCT02053350Phase 2

Alanyl-glutamine Supplementation of Standard Treatment for C. Difficile Infection

Terminated
NCT01832636Phase 3

Intervention and Mechanisms of Alanyl-Glutamine for Inflammation, Nutrition, and Enteropathy

Completed
NCT00133562Phase 3

HIAS II - Study of Nutritional Supplementation in Hospitalized Children With Persistent Diarrhea or Malnutrition

Withdrawn
NCT00338221Phase 3

Clinical Trial of Alanyl-Glutamine or Glycine in Children With Persistent Diarrhea or Malnutrition

Withdrawn

All 6 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
6